Autologous CD19directed chimeric antigen receptorT cell is an effective and safe treatment to refractory or relapsed diffuse large Bcell lymphoma

Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma

21:27 EST 8 Jan 2019 | Nature Publishing

More From BioPortfolio on "Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma"